Recent Updates — PBSV

Pharma-Bio Serv reported financial results for the quarter ended July 31, 2026, with revenues of approximately $2.3 million, an increase of $0.4 million year-over-year. The company posted a net loss of $14 thousand for the quarter, representing a $190 thousand improvement compared to the prior year period. For the nine-month period ended July 31, 2026, revenues reached approximately $7.3 million, up $0.5 million from the previous year, while net income was approximately $252 thousand, an improvement of $352 thousand. The company operates in the pharmaceutical and biotechnology regulatory compliance consulting industry.